🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & Access2026 payer coverage update — GLP-1 formulary changes by insurer Page 15

2026 payer coverage update — GLP-1 formulary changes by insurer

InsuranceTom Mon, Feb 26, 2024 at 4:00 PM 377 replies 33,823 viewsPage 15 of 20
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
May 29, 2024 at 7:17 AM#71
bri_stats said:
One practical note: write down what you did and when, before you need it.

This is where I part company with the consensus forming above. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Last edited: May 29, 2024 at 9:17 AM
27 0NurseKim_ATL, paul_denver, TinaHashiRN and 24 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
May 30, 2024 at 11:29 PM#72
bri_stats said:
One practical note: write down what you did and when, before you need it.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

28 1MariaRD, AussieAnna, BethLabQueen and 25 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Jun 1, 2024 at 3:40 PM#73
bri_stats said:
One practical note: write down what you did and when, before you need it.

Thank you for spelling out the reasoning rather than just the conclusion.

Last edited: Jun 1, 2024 at 4:40 PM
29 2tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 26 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jun 3, 2024 at 7:50 AM#74

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

30 3Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 27 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Jun 4, 2024 at 11:59 PM#75
Dr.PeteFamMed said:
The useful move here is to separate what is established from what is widely repeated.

Adding a me-too, because a thread of one person's experience is not much use.

31 4lucas_SP_BR, lisa_labSD, adam_van and 28 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register